SMYD2 and acute kidney injury: In this study, we found that kidney SMYD2 expression and its activity were increased in a murine model of cisplatin-induced AKI and that inhibition of SMYD2 by AZ505 improves renal function, attenuates kidney tubular injury and inflammation, and promotes kidney tubular cell proliferation.